Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 2, 2009, Pages 275-287

  Khan, Mahmood ^a   Meduru, Sarath ^a   Mohan, Iyyapu K ^a   Kuppusamy, M Lakshmi ^a   Wisel, Sheik ^a   Kulkarni, Aditi ^a   Rivera, Brian K ^a   Hamlin, Robert L ^b   Kuppusamy, Periannan ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Echocardiography; Electrocardiography; Hyperbaric oxygen; Mesenchymal stem cell; Myocardial infarction; Myocardial oxygenation; Stem cell therapy

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA1 INTEGRIN; CONNEXIN 43; FERRIC FERROCYANIDE; OXYGEN; SUPERPARAMAGNETIC IRON OXIDE; TROPONIN T; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADJUVANT THERAPY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENGRAFTMENT; FUNCTIONAL ASSESSMENT; GRAFT SURVIVAL; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE HYPERTROPHY; HYPERBARIC OXYGEN; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QRS COMPLEX; RAT; VECTORCARDIOGRAPHY;

ACTION POTENTIALS; ANIMALS; ANTIGENS, CD29; BLOOD VESSELS; CONNEXIN 43; FERRIC COMPOUNDS; FIBROSIS; HYPERBARIC OXYGENATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PARTIAL PRESSURE; RATS; RATS, INBRED F344; RECOVERY OF FUNCTION; TROPONIN T; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT;

RATTUS;

EID: 67649121808     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.04.005     Document Type: Article

References (35)

1. Murry C.E., Field L.J., and Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112 (2005) 3174-3183
2. Dimmeler S., Burchfield J., and Zeiher A.M. Cell-based therapy of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 208-216
3. Robey T.E., Saiget M.K., Reinecke H., and Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 45 (2008) 567-581
4. Li W., Ma N., Ong L.L., Nesselmann C., Klopsch C., Ladilov Y., et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25 (2007) 2118-2127
5. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9 (2003) 1195-1201
6. Pasha Z., Wang Y., Sheikh R., Zhang D., Zhao T., and Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc. Res. 77 (2008) 134-142
7. Seeger F.H., Zeiher A.M., and Dimmeler S. Cell-enhancement strategies for the treatment of ischemic heart disease. Nat. Clin. Pract. Cardiovasc. Med. 4 Suppl 1 (2007) S110-S113
8. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25 (2007) 1015-1024
9. Wisel S., Khan M., Kuppusamy M.L., Mohan I.K., Chacko S.M., Rivera B.K., et al. Pharmacological preconditioning of mesenchymal stem cells with Trimetazidine protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J Pharmacol Exp Therap 329 (2009) 543-550
10. Tibbles P.M., and Edelsberg J.S. Hyperbaric-oxygen therapy. N. Engl. J. Med. 334 (1996) 1642-1648
11. Thackham J.A., McElwain D.L., and Long RJ. The use of hyperbaric oxygen therapy to treat chronic wounds. A Rev. Wound Repair Regen. 16 (2008) 321-330
12. Yogaratnam J.Z., Laden G., Madden L.A., Seymour A.M., Guvendik L., Cowen M., et al. Hyperbaric oxygen: a new drug in myocardial revascularization and protection?. Cardiovasc. Revasc. Med. 7 (2006) 146-154
13. Yogaratnam J.Z., Laden G., Guvendik L., Cowen M., Cale A., and Griffin S. Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide?. J. Surg. Res. (2007)
14. Sterling D.L., Thornton J.D., Swafford A., Gottlieb S.F., Bishop S.P., Stanley A.W., et al. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation 88 (1993) 1931-1936
15. Dekleva M., Neskovic A., Vlahovic A., Putnikovic B., Beleslin B., and Ostojic M. Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. Am. Heart J. 148 (2004) E14
16. Thom S.R., Bhopale V.M., Velazquez O.C., Goldstein L.J., Thom L.H., and Buerk D.G. Stem cell mobilization by hyperbaric oxygen. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1378-H1386
17. Wisel S., Chacko S.M., Kuppusamy M.L., Pandian R.P., Khan M., Kutala V.K., et al. Labeling of skeletal myoblasts with a novel oxygen-sensing spin probe for noninvasive monitoring of in situ oxygenation and cell therapy in heart. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1254-H1261
18. Khan M., Kutala V.K., Wisel S., Chacko S.M., Kuppusamy M.L., Kwiatkowski P., et al. Measurement of oxygenation at the site of stem cell therapy in a murine model of myocardial infarction. Adv. Exp. Med. Biol. 614 (2008) 45-52
19. Khan M., Kutala V.K., Vikram D.S., Wisel S., Chacko S.M., Kuppusamy M.L., et al. Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H2129-H2139
20. Hamlin R.L. The QRS electrocardiogram, epicardiogram, vectorcardiogram and ventricular excitation of swine. Am. J. Physiol. 198 (1960) 537-542
21. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103 (1999) 697-705
22. Shake J.G., Gruber P.J., Baumgartner W.A., Senechal G., Meyers J., Redmond J.M., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73 (2002) 1919-1925 [discussion 26]
23. Al-Khaldi A., Al-Sabti H., Galipeau J., and Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann. Thorac. Surg. 75 (2003) 204-209
24. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
25. Stavitsky Y., Shandling A.H., Ellestad M.H., Hart G.B., Van Natta B., Messenger J.C., et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomized multicenter study. Cardiology 90 (1998) 131-136
26. Han C., Lin L., Zhang W., Zhang L., Lv S., Sun Q., et al. Hyperbaric oxygen preconditioning alleviates myocardial ischemic injury in rats. Exp. Biol. Med. (Maywood). 233 (2008) 1448-1453
27. Tritto I., Ambrosio G., Capelli-Bigazzi M., Perrone-Filardi P., Lepore S., Tifano R., et al. Effects of hyperbaric oxygen therapy on experimental infarct size: Salvage versus delay of myocardial necrosis. J. Appl. Cardiol. 6 (1991) 359-366
28. Tahep Id.P., Valen G., Starkopf J., Kairane C., Zilmer M., and Vaage J. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart. Life Sci. 68 (2001) 1629-1640
29. Cabigas B.P., Su J., Hutchins W., Shi Y., Schaefer R.B., Recinos R.F., et al. Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc. Res. 72 (2006) 143-151
30. Yang J., Zhou W., Zheng W., Ma Y., Lin L., Tang T., et al. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107 (2007) 17-29
31. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
32. Sen C.K., Khanna S., Babior B.M., Hunt T.K., Ellison E.C., and Roy S. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem. 277 (2002) 33284-33290
33. Ijichi H., Taketomi A., Yoshizumi T., Uchiyama H., Yonemura Y., Soejima Y., et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy. J. Hepatol. 45 (2006) 28-34
34. Haider H., Jiang S., Idris N.M., and Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1{alpha}/CXCR4 signaling to promote myocardial repair. Circ. Res. 103 (2008) 1300-1308
35. Rose R.A., Jiang H., Wang X., Helke S., Tsoporis J.N., Gong N., et al. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells 26 (2008) 2884-2892